Director Sells $5.66 Million in AEHR Stock Near 52-Week High
AEHR has more than doubled off its 52-week low of $7.71 on elevated volume (2.0× avg).
Summary
A director of AEHR Test Systems sold $5.66 million worth of common stock in open market transactions, reducing their holdings significantly.
Key Events · Ownership and Investor Activity · AEHR
-
Director Sells Significant Stake
Geoffrey G. Scott, a Director of AEHR Test Systems, disposed of 60,000 shares of common stock for a total value of $5,660,000 on April 21, 2026.
-
Holdings Reduced
Following these transactions, the director's post-transaction holdings are 50,686 shares.
-
Sale Near 52-Week High
The sales occurred with prices ranging from $91.00 to $95.00, while the stock is trading near its 52-week high of $99.67.
-
Part of Broader Insider Selling Trend
This transaction adds to a net insider selling of over $32 million in the last 90 days, indicating a pattern of distribution among company insiders.
Analysis · AEHR · Industrial Applications And Services
This substantial open market sale by a director, occurring near the company's 52-week high, suggests the insider is taking profits. The sale follows a recent positive announcement of a record production order but also comes amidst a backdrop of recent financial weakness and the establishment of a new At-The-Market (ATM) equity offering. This transaction contributes to a broader pattern of insider distribution observed over the last 90 days.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AEHR was trading at $96.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $7.71 to $99.67. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.